Adamas Wins FDA OK for the First and Only Drug for Parkinson's Dyskinesia Drug Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Mark Terry, BioSpace.com… Source: BioSpace You Might Also Like FDA Expands Bristol-Myers Squibb’s Opdivo Dosing Schedule March 5, 2018 Unum Therapeutics Looks to File IPO, Reveals Patient Deaths in Early Clinical Trial March 4, 2018 TG Therapeutics Announces Updated Results From the Ongoing Phase II Study of Ublituximab in Patie… February 1, 2018
TG Therapeutics Announces Updated Results From the Ongoing Phase II Study of Ublituximab in Patie… February 1, 2018
